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Abstract
Background: Health care associated transmission of Mycobacterium tuberculosis (TB) is well described. A previous
survey of infection control (IC) practices at clinical research sites in low and middle income countries (LMIC) funded
by the National Institute of Allergy and Infectious Diseases (NIAID) conducting HIV research identified issues with
respiratory IC practices. A guideline for TB IC based on international recommendations was developed and
promulgated. This paper reports on adherence to the guideline at sites conducting or planning to conduct TB
studies with the intention of supporting improvement.
Methods: A survey was developed that assessed IC activities in three domains: facility level measures, administrative
control measures and environmental measures. An external site monitor visited each site in 2013–2014, to complete
the audit. A central review committee evaluated the site-level survey and results were tabulated. Fisher’s exact test was
performed to determine whether there were significant differences in practices at sites that had IC officers versus sites
that did not have IC officers. Significance was assessed at p</=.05
Results: Seven of thirty-three sites surveyed (22 %) had all the evaluated tuberculosis IC (TB IC) elements in place.
Sixty-one percent of sites had an IC officer tasked with developing and maintaining TB IC standard operating
procedures. Twenty-two (71 %) sites promptly identified and segregated individuals with TB symptoms. Thirty (93 %)
sites had a separate waiting area for patients, and 26 (81 %) collected sputum within a specific well-ventilated area that
was separate from the general waiting area. Sites with an IC officer were more likely to have standard operating
procedures covering TB IC practices (p = 0.02) and monitor those policies (p = 0.02) and perform regular surveillance of
healthcare workers (p = 0.02). The presence of an IC officer had a positive impact on performance in most of the TB IC
domains surveyed including having adequate ventilation (p = 0.02) and a separate area for sputum collection (p = 0.02)
Conclusions: Specific and targeted support of TB IC activities in the clinical research environment is needed and is
likely to have a positive and sustained impact on preventing the transmission of TB to both health care workers and
vulnerable HIV-infected research participants.
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Background
Time and attention to infection control (IC) activities
improves patient and staff infection rates [1, 2] and re-
duces costs associated with health care [3]. In resource
limited settings, the contribution of health care associ-
ated infections to patient morbidity may be underesti-
mated and significant [4]. Health care associated
transmission of Mycobacterium tuberculosis (TB) is well
described in both patients and health care workers and
outbreaks of tuberculosis including extensively drug re-
sistant TB (XDR TB) have been linked to the health care
environment in several resource limited settings [5, 6].
Prevention of health care associated TB transmission,
therefore, is an urgent IC need in resource-limited
settings.
Recommendations regarding facilities level manage-
ment activities, administrative, and environmental IC
measures and personal protection practices [7–9] have
been developed by several agencies including the World
Health Organization (WHO) and the US Centers for
Disease Control (CDC). In the United States, regulations
require an “active program for the prevention, control,
and investigation of infections and communicable dis-
eases” [10], and wide implementation of a variety of IC
practices in the last 20 years has resulted in a substantial
decrease in health care associated transmission of TB
[7]. In resource limited settings, there are no regulatory
requirements, and uptake of guidance has been incom-
plete. Adherence to international guidelines has been
evaluated in several settings and compliance with the full
complement of recommendations is rare. In particular
the presence of a written IC plan, staff and patient edu-
cation, segregation of patients with symptoms and yearly
evaluation of health care workers are uncommonly
found [11–13]. Two recent studies in South Africa
assessed the impact of health care worker education
about IC principles and the results are worrisome [14,
15]. Although a higher level of training was associated
with better knowledge of TB IC, this knowledge did not
always translate into better TB IC (IC) practice [14]. Im-
portantly, among health care workers (HCW) the rates
of smear positive TB were higher than in the general
population and the audit cycle (standard setting, evalu-
ation of practice and outcomes and re-audit) had no im-
pact on rates of incident TB in this group. A general
review of IC practices including respiratory and hand
hygiene, IC organizational structure and blood safety at
NIAID funded clinical research sites was conducted in
2011 and 2012 [16]. Several important issues were iden-
tified at the sites in low and middle income countries,
the most urgent of which was the need for a network
policy for TB IC. A guideline for TB IC was developed
based on existing international recommendations and
promulgated early in 2012. External monitors were then
sent to all sites to assess adherence to the guideline. This
paper reports on uptake of these recommendations at
clinical sites conducting or planning to conduct TB-
related ACTG clinical trials with the objective of im-
proving participant and staff safety.
Methods
Thirty-three NIAID-funded clinical research sites lo-
cated in LMIC in the AIDS Clinical Trials Group
(ACTG) and the International Maternal, Pediatric, Ado-
lescent AIDS Clinical Trials Network (IMPAACT) net-
works signaled their intention to participate in clinical
trials involving TB. These sites were given the ACTG
TB IC guideline, and a survey was developed to assess
adherence to the ACTG guideline [Additional file 1].
This survey tool was piloted at five representative clin-
ical trial sites and refined to improve the ease of its ad-
ministration for both the monitor and the site staff as
well as to address minor technical and scientific issues.
The sites were then monitored by an objective external
monitoring organization (PPD) to assess adherence to
the guideline using the survey. The external monitoring
organization visited each site and directly observed IC
practice between February 2013 and December 2014 and
documented adherence to the ACTG guideline using the
survey tool. The results of each site survey were
reviewed by an ACTG committee in real time, and feed-
back was given to each site in order to improve practice.
Notionally the survey was divided into three key com-
ponents of TB IC practice: facility level measures, ad-
ministrative control measures and environmental
control measures (see Table 1). Facilities level activities
that were evaluated included whether an air flow assess-
ment for clinic areas had been performed, whether pa-
tients with symptoms and cough were identified and
separated, and whether sputum collection was separate
from the patient care areas and collected in an appropri-
ate facility. Waiting areas were evaluated for crowding
and ventilation. The presence of policies for annual TB
surveillance of health care workers (HCW) and policies
for HIV Post-Exposure Prophylaxis (PEP) and Isoniazid
Preventive Therapy (IPT) were noted as well as quality
management practices for regular assessment of adher-
ence to written policies and standard operating proce-
dures. External monitors assessed whether personal
protective equipment (PPE) including N95 masks or
equivalent were available and fit tested. Policies for hand
hygiene and appropriate instruction were recorded as
present or absent.
Two reviewers (CG and GT) summarized and tabu-
lated the information, percentages of positive responses
were recorded and a yes/no assessment to open ended
questions was provided. The answers to the elements in
the assessment tool provided a measure of adherence to
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the ACTG IC guideline. A Fisher’s exact test was per-
formed to determine whether there were significant dif-
ferences in practices at sites that had IC officers versus
sites that did not have IC officers. Significance was
assessed at p</=.05
No ethical review was required as this was not re-
search involving human subjects.
Results
Thirty one of thirty-three sites had complete responses
to the IC survey. Seven sites (22 %) had all the surveyed
elements already in place.
Facilities level control
Sixty-one percent of sites had an IC officer tasked with
developing and maintaining SOPs. Just over half the sites
had SOPs in place for the major IC domains, and 81 %
(25/31) of these performed and documented regular au-
dits of their SOPs. Health care workers were required to
have annual screening for tuberculosis at 61 % (19/31)
of sites. Screening could consist of any of a symptom
screen, a CXR or a tuberculin skin test.
Administrative
Most sites had some TB IC administrative support.
Seventy-one percent of sites promptly identified individ-
uals with TB symptoms and segregated them.
Environmental
Ninety-three percent of sites (28/30) had a separate wait-
ing area for patients, and collected sputum in a specific
area (81 %) that was separate from the general area and
well ventilated as judged by the auditor. Sites were likely
to promote cough hygiene by having signs posted,
Table 1 Components of the site audit tool and response rates from 32 sites
Key components Indicators Details Result
Facility level
measures
Facility plan for implementation
of TB infection control
Appointment of facility based IC officer 61.0 %
Policies and procedures (SOPs) for
rapid identification, and isolation of TB cases
61.3 %
Optimized space Waiting area ventilated and uncrowded 93.3 %
Annual surveillance of health
care workers (HCWs) is conducted




TB IC Policies monitored 1. Policies evaluated 80.6 %
2. Documentation of frequency of




of patients with symptoms




2. Use of separate waiting rooms
or outdoor waiting areas
Cough hygiene Education 1. Cough hygiene education signs 80.6 %
2. Resources for hand washing/disinfection
3. Masks for coughing patients
and others with respiratory infection.
Hand hygiene Policy 1. Written policy or appropriate
instructions for hand hygiene
67.7 %
2. Instructions posted
3. Availability and use of non-touch
bins throughout the high-risk areas




Ventilation system is optimized Air flow assessment performed 54.8 %
Ventilation and/or air cleaning Windows open, use of other
ventilation, air cleaning methods
80.6 %
Personal Protective Equipment
(PPE) (PPE, N95 masks or equivalent, fit testing for masks)
PPE available 96.8 %
(N95 Masks), gloves and respirators 87.1 %
Fit Testing: written fit testing
procedures, records for fit testing
43.3 %
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available disposable handkerchiefs, and disposable masks
for patients (81 % of sites). There was adequate ventila-
tion with measurement of airflow in the waiting areas,
examination rooms and specimen collection areas at
81 % of sites. Personal protective equipment was com-
monly present (97 %), including N95 masks and respira-
tors (87 %), but masks were not commonly fit tested
(43 %–13/30 sites).
The sites with an IC officer in general performed sig-
nificantly better in most but not all of the domains sur-
veyed (see Table 2). Specifically, sites with an IC officer
were more likely to have standard operating procedures
for important IC practices (p = 0.02; 95 % confidence in-
tervals 9.0 %, 71.5 %) and to monitor adherence to these
practices (p = 0.02; 6.2–63.9 %) were more likely to per-
form surveillance of health care workers (p = 0.02; 8.8–
72.5 %). These sites were also more likely to have ad-
equate ventilation (p = 0.02; 5.9– 64.2 %) and separate
areas for sputum collection (p = 0.02; 6.0– 64.3 %).
Discussion
The results of our study provide an assessment tool for
continuing improvement in the area of TB IC in the
clinical research setting. The clinical research environ-
ment provides an opportunity to model and evaluate
best practices for clinical care. Typically the patient vol-
ume is less than in the clinical care setting and there are
rigorous standards for good clinical practice with which
all members of the research team are required to be
certified. Indeed, many have argued that the research en-
vironment should be held to the highest achievable
standard of clinical care [17] which may differ from local
standard of care. Nevertheless, we identified important
gaps in TB IC knowledge and areas for improvement of
IC practices. Most of the NIAID Division of AIDS
(DAIDS) sponsored clinical sites had some basic TB ele-
ments for IC practices in place and a few sites had all
the important elements in place. The most important
finding was that when a trained IC officer was present,
the facility was more likely to have SOPs in place for the
major TB IC domains, to segregate sputum collection
from the general study participant areas, and to provide
annual surveillance of health care workers for TB infec-
tion. The TB IC survey was used to make site-specific
recommendations in real time for improvement of TB
infection prevention practices and capacity building. For
example, standardized instructions were developed for
assessing airflow and inexpensive equipment for its
measurement were sourced. Having the elements in
place did not imply that the practices were the best
available, but they provided a framework in which im-
provement could occur. For example, having a policy of
yearly screening of health care workers already in place,
means that the specifics of the screening can then be
evaluated as a next step.
The effect of specific IC activities is difficult to meas-
ure but evaluation of adherence to specific recommen-
dations will be a helpful next step. Despite appropriate
Table 2 Role of IC officer






4 (33.3 %) 15
(78.9 %)
45.6 % (9.0, 71.5) 0.022






16.7 % (−4.1, 42.5) 0.152
Surveillance of HCW 19
(61.3 %)
4 (33.3 %) 15
(78.9 %)
45.6 % (8.8, 72.5) 0.022
TB IC policies monitored 25
(80.6 %)
7 (58.3 %) 18
(94.7 %)
36.4 % (6.2, 63.9) 0.022
ID, Separation of patients with
symptoms
22 (71 %) 7 (58.3 %) 15
(78.9 %)
20.6 % (−12.8, 52.6) 0.253
Separate sputum collection 25
(80.6 %)
7 (58.3 %) 18
(94.7 %)
36.4 % (6.0, 64.3) 0.022
Ventilation 25
(80.6 %)
7 (58.3 %) 18
(94.7 %)







8.3 % (−8.0, 33.2) 0.387






6.1 % (−18.3, 35.2) 0.63
Fit testing for masks 13
(43.3 %)
3 (25 %) 10
(55.6 %)
30.6 % (−6.0, 59) 0.141
Number and percent of positive responses for each domain by whether a site had an IC officer present. The p-value is a comparison of the proportions between
sites with IC officers and without IC officers
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TB IC training, it still may be difficult to prevent health
care associated transmission of TB. The administrative
component of IC practice such as the presence of an IC
practitioner, policies and procedures for handling pa-
tients and staff members with infections and documen-
tation of those procedures, has been demonstrated to
lead to improved outcomes in resource rich environ-
ments [18, 19]. A review of the effect of IC interventions
in low and middle income countries concluded that ad-
ministrative controls have the potential to reduce new
TB infections in health care workers [6]. There also may
be an incremental benefit to engineered solutions such
as the use of mechanical ventilation and ultraviolet (UV)
lights to limit TB infectiousness [6]. In resource-limited
settings high clinical burden, shortages of the materiel
required for universal precautions (eg PPE), minimal
support from health care management for these activ-
ities and minimal or no regulatory requirements for
compliance to IC procedures make adhering to IC rec-
ommendations difficult. High staff turnover provides an
additional challenge. The effect of a specific single inter-
vention, is therefore harder to prove and is less well
studied
Health care workers may be an important link in the
transmission cycle of TB in clinical research settings: the
risk to clinic staff for TB acquisition may be consider-
able and staff with active TB may put other vulnerable
patients at risk. The prevalence of TB infection and dis-
ease is high in health care workers compared to the gen-
eral population [6, 20]. Latent TB infection is common
and in a prospective study, HCW experienced incident
latent TB infection almost five times more than a con-
trol population [20]. A recent meta-analysis found that
in high TB prevalence countries, 81 % of active TB dis-
ease cases in health care workers was attributable to ex-
posure in their work environment [21]. When active
surveillance of health care workers is undertaken, un-
diagnosed pulmonary disease is not uncommon, and of
those with active pulmonary TB multidrug resistant
strains comprise an important component [22–24].
Rates of admission to hospital for TB were evaluated in
Kwa Zulu-Natal and the estimated incidence of MDR
TB hospitalization for HCW was more than five times
that of the non-health care worker population and
HCW represented a significant proportion of the XDR
cases [25]. Universal screening for TB at the workplace,
undifferentiated by HIV status is now recommended by
the WHO [26] although few resource limited countries
undertake regular screening [6, 27] of any type.
Evaluation of adherence to specific recommendations
will be a helpful next step at the DAIDS funded clinical
research sites. Documentation of adherence to SOPs
and other surveillance activities will identify other gaps
at a site level and continued surveillance of the
aggregate performance will provide important informa-
tion that will allow for the deployment of targeted re-
sources. Biologically relevant surrogate markers for
assessing the success of IC measures remain elusive in
the outpatient environment, although a decrease in new
cases of TB infection and disease in HCW has been pro-
posed as a measurement of TB IC success [15, 27–31].
Quantification on a population level of TB burden using
various methodologies including Xpert probe frequency
is a novel technique that may provide additional infor-
mation [32].
Conclusions
In our study the presence of an IC practitioner was more
likely to be associated with the availability of basic ele-
ments of IC practice, however this was less influential
on overall TB specific IC practices than we expected. It
may be that the role and job description of the IC officer
needs to be standardized and ownership of the principles
by the entire site staff may be required. Some experts
have argued that the implementation of administrative
level controls such as the identification and isolation of
individuals with cough and the provision of preventive
and care services for health care workers should be pri-
oritized [6, 11], however the contribution of each com-
ponent of an effective IC program has not been
evaluated and it may be that the presence of managerial
support of resources including commitment to the es-
tablishment, implementation and monitoring of IC pol-
icies is critical. Our study lends credence to this notion,
and suggests that support of an individual specifically
tasked with IC activities may improve the overall quality
of care at and reduce nosocomial transmission of infec-
tions to HCW and trial participants. Regular TB surveil-
lance of health care workers, site study personnel and
research participants is clearly an important component
of IC practice in resource limited settings and may pro-
vide an outcome measure of IC activities. Inculcating a
best practices culture of infection prevention and con-
tinuous quality improvement will help ensure that all
site personnel adhere to and benefit from basic IC prin-
ciples. A research agenda for TB IC in areas of high
prevalence is critically needed in order to prioritize ef-
forts and to focus attention on this acute need.
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